Net Cash Provided by (Used in) Operating Activities |
-595M |
USD |
-16.4% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
1.12B |
USD |
-16.8% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-545M |
USD |
+54.1% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
4K |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
3K |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
25K |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
3.15B |
USD |
-7.5% |
Mar 31, 2024 |
Q1 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
34M |
USD |
-5.56% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
0 |
USD |
-100% |
Dec 31, 2023 |
Q4 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.25 |
pure |
+38.9% |
Dec 31, 2023 |
Q4 2023 |
Deferred Tax Assets, Gross |
3.32B |
USD |
+1.56% |
Dec 31, 2023 |
Q4 2023 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-1.29B |
USD |
-36.6% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
1.83B |
USD |
+46.5% |
Dec 31, 2023 |
Q4 2023 |
Deferred Federal Income Tax Expense (Benefit) |
-378M |
USD |
-143% |
Dec 31, 2023 |
Q4 2023 |
Unrecognized Tax Benefits |
14M |
USD |
0% |
Dec 31, 2023 |
Q4 2023 |
Additional Paid in Capital |
17.5B |
USD |
-1.5% |
Mar 31, 2024 |
Q1 2024 |
Current Federal Tax Expense (Benefit) |
-5M |
USD |
+94.3% |
Dec 31, 2023 |
Q4 2023 |
Deferred Tax Assets, Net of Valuation Allowance |
3.32B |
USD |
+2.12% |
Dec 31, 2023 |
Q4 2023 |